Evaluating the Risks and Benefits of Genetic and Pharmacologic Interventions for Down Syndrome: Views of Parents.
Sign Up to like & getrecommendations! Published in 2020 at "American journal on intellectual and developmental disabilities"
DOI: 10.1352/1944-7558-125.1.1
Abstract: Researchers are investigating new technologies to mitigate or prevent symptoms of Down syndrome (DS), including chromosome silencing and pharmacotherapy. We surveyed parents of individuals with DS to assess their opinions on two hypothetical scenarios describing… read more here.
Keywords: pharmacologic interventions; evaluating risks; benefits genetic; risks benefits ... See more keywords